However, clinically meaningful improvements, though occurring more frequently with ibrutinib than chlorambucil, did not reach statistical significance [ 52 ].
← all excerpts
First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era.
1
—
—